MOHAN C MADALA

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease OKEMOS, MI NPI 1295949030

General Payments — all program years on this page

$5,846.99

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 266
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,003.96 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,003.9621

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $503.8536
2019 $463.5634
2020 $259.0216
2021 $1,067.2647
2022 $1,348.0870
2023 $1,201.2642
2024 $1,003.9621

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077689797 Biosense Webster, Inc. $15.97 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078052860 Janssen Pharmaceuticals, Inc $49.45 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042674 Novartis Pharmaceuticals Corporation $15.12 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042676 Novartis Pharmaceuticals Corporation $21.32 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042684 Novartis Pharmaceuticals Corporation $23.57 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087042686 Novartis Pharmaceuticals Corporation $27.58 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101629066 E.R. Squibb & Sons, L.L.C. $23.19 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101629070 E.R. Squibb & Sons, L.L.C. $18.21 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104206783 AstraZeneca Pharmaceuticals LP $117.97 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104238031 AstraZeneca Pharmaceuticals LP $35.89 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104782682 AstraZeneca Pharmaceuticals LP $4.46 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115890190 Amgen Inc. $82.06 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117616772 Amgen Inc. $15.35 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117616774 Amgen Inc. $73.17 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117616776 Amgen Inc. $27.10 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117616778 Amgen Inc. $45.68 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124969687 Abbott Laboratories $145.88 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131604462 PFIZER INC. $15.56 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140134173 Inari Medical, Inc. $172.81 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146897412 Philips North America LLC $38.87 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152978549 ShockWave Medical, Inc $34.75 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.